Recent 8-K filings for HIT

• May 13, 2026, 5:30 PM ET other material materiality 0.70 negative item 7.01item 9.01

  Health In Tech Q1 revenue up 9% YoY to $8.8M; guides FY2026 revenue $45-50M; EBITDA turns negative on growth spend

  Q1 2026 total revenue $8.8M (+9% YoY); adjusted EBITDA -$1.3M vs. +$1.2M in Q1 2025.

• May 13, 2026, 4:21 PM ET earnings materiality 0.60 neutral item 2.02item 7.01item 9.01

  Health In Tech Q1 revenue up 9.4% to $8.8M; net loss of $1.6M vs prior year profit

  Revenue $8.8M (+9.4% YoY); net loss $1.6M ($0.03 diluted loss) vs net income $0.5M in Q1 2025.

• March 27, 2026, 7:59 PM ET other material materiality 0.65 positive item 1.01item 9.01

  Health In Tech closes $7.0M PIPE financing, issues 5.6M shares at $1.25/share

  Gross proceeds of $7.0M from private placement with institutional and accredited investors.

• March 26, 2026, 7:59 PM ET other material materiality 0.60 neutral item 1.01item 3.02item 7.01item 9.01 ◈ Material Agreements ×3

  Health In Tech raises $7.0M in PIPE at $1.25 per share

  Gross proceeds of ~$7.0 million from 5,600,000 shares at $1.25 per share.

• March 25, 2026, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 7.01item 9.01

  Health In Tech reports FY2025 revenue $33.3M (+71% YoY); guides FY2026 $45-50M

  Full year 2025 revenue $33.3M (+71% YoY); net income $1.3M (+91%); Adjusted EBITDA $4.1M (+81%).

• November 12, 2025, 6:59 PM ET earnings materiality 0.75 positive item 2.02item 7.01item 9.01

  Health In Tech Q3 revenue $8.5M (+90% YoY); nine-month revenue $25.8M, 132% of FY2024

  Revenue $8.5M, up 90% YoY; nine-month revenue $25.8M, 132% of full-year 2024.

• July 28, 2025, 7:59 PM ET leadership materiality 0.65 negative item 5.02

  Health In Tech terminates COO Chris Kurtenbach effective July 22, 2025

  Chris Kurtenbach's at-will employment as COO terminated by board on July 22, 2025.

• July 21, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 7.01item 9.01

  Health In Tech Q2 revenue $9.3M (+86% YoY), adj. EBITDA $1.6M (+134% YoY)

  Revenue $9.3M, up 86% YoY; first-half revenue $17.3M, 89% of full-year 2024.

• April 29, 2025, 7:59 PM ET regulatory materiality 0.75 negative item 3.01

  Health In Tech receives Nasdaq bid-price deficiency notice; 180 days to cure

  On April 28, 2025, Nasdaq notified Health In Tech that its Class A common stock (HIT) failed to maintain minimum $1.00 bid price for 30 consecutive business days.

• April 14, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 7.01item 9.01

  Health In Tech Q1 rev $8.0M (+56% YoY); pretax income triples to $0.7M

  Revenue $8.0M, up 56% YoY; income before tax $0.7M (+257%); adjusted EBITDA $1.2M (vs $0.5M).

• March 17, 2025, 7:59 PM ET earnings materiality 0.70 negative item 2.02item 7.01item 9.01

  Health In Tech FY2024 revenue $19.5M (+1.8%); adj. EBITDA falls to $2.3M from $4.8M; leadership reshuffled

  Full-year 2024 revenue $19.5M (+1.8% YoY); income from continuing ops $0.7M vs $2.5M in 2023.

• December 26, 2024, 6:59 PM ET other material materiality 0.80 positive item 1.01item 7.01item 9.01

  Health In Tech completes IPO of 2.3M shares at $4.00, raising $9.2M gross

  Priced IPO of 2,300,000 Class A shares at $4.00 per share on Dec 20, 2024.

Executive changes

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.80 · Median 0.45 · Most common event other_material

7 positive 4 negative 17 neutral

source · HIT on sec.gov